LIGUA, Inc. (JP:7090)
:7090
Want to see JP:7090 full AI Analyst Report?
Top Page
LIGUA, Inc.
(7090)
Select Model
Select Model
Rating:40Underperform
Price Target:
¥846.00
▼(-8.04% Downside)
Action:Downgraded
Date:05/16/26
The score is held down primarily by weak financial performance (declining revenue, ongoing losses, and thin equity despite better recent free cash flow) and bearish technicals (price below key moving averages with negative MACD and weak RSI/Stoch). Valuation is also a drag due to a negative P/E and no dividend data.
Positive Factors
Improving cash generation
A sustained return to positive and growing operating and free cash flow provides durable internal funding. This improves near-term liquidity, funds necessary investments or further deleveraging, and cushions the business against earnings volatility, supporting resilience over the next several months.
Negative Factors
Sustained revenue contraction
Consecutive double‑digit top‑line declines erode scale, weaken market position and reduce operating leverage. Persistent revenue contraction limits ability to absorb fixed costs and hampers margin recovery, making medium‑term profitability restoration more challenging without a clear turnaround.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving cash generation
A sustained return to positive and growing operating and free cash flow provides durable internal funding. This improves near-term liquidity, funds necessary investments or further deleveraging, and cushions the business against earnings volatility, supporting resilience over the next several months.
Read all positive factors
LIGUA, Inc. (7090) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥1.44B
Dividend YieldN/A
Average Volume (3M)15.67K
Price to Earnings (P/E)―
Beta (1Y)0.70
Revenue Growth-15.77%
EPS Growth21.26%
CountryJP
Employees140
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-214.12
Shares Outstanding1,611,800
10 Day Avg. Volume7,040
30 Day Avg. Volume15,666
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)6.02
Price to Sales (P/S)2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LIGUA, Inc. Business Overview & Revenue Model
Company Description
Ligua Inc., a consultancy company, engages in the provision of management support services in the healthcare industry. It operates through two segments: Orthopedic Clinic Solutions Business and Financial Services Business. The company offers ortho...
LIGUA, Inc. Financial Statement Overview
Summary
Income Statement
34
Negative
Balance Sheet
22
Negative
Cash Flow
58
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.74B | 2.42B | 2.87B | 3.43B | 2.84B | 3.20B |
| Gross Profit | 1.65B | 1.42B | 1.71B | 1.88B | 1.22B | 1.63B |
| EBITDA | -81.91M | -67.19M | -90.80M | 274.91M | -258.56M | 359.47M |
| Net Income | -319.01M | -241.03M | -301.00M | 104.08M | -774.47M | 72.41M |
Balance Sheet | ||||||
| Total Assets | 2.91B | 2.49B | 3.14B | 3.87B | 3.37B | 3.28B |
| Cash, Cash Equivalents and Short-Term Investments | 1.18B | 1.19B | 1.35B | 1.33B | 1.17B | 1.38B |
| Total Debt | 1.93B | 1.62B | 2.10B | 2.39B | 2.26B | 1.51B |
| Total Liabilities | 2.65B | 2.32B | 2.82B | 3.26B | 3.02B | 2.14B |
| Stockholders Equity | 254.38M | 176.88M | 319.81M | 604.90M | 353.17M | 1.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 253.57M | 146.47M | -5.19M | -384.94M | 40.15M |
| Operating Cash Flow | 0.00 | 263.68M | 163.38M | 2.83M | -328.22M | 80.06M |
| Investing Cash Flow | 0.00 | -41.85M | 147.72M | 10.78M | -600.71M | -474.61M |
| Financing Cash Flow | 0.00 | -390.37M | -290.02M | 137.19M | 716.85M | -154.13M |
LIGUA, Inc. Technical Analysis
Negative
920.00
Price Trends
986.88
Negative
954.02
Positive
1026.90
Negative
Market Momentum
-3.52
Positive
42.30
Neutral
45.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7090, the sentiment is Negative. The current price of 920 is below the 20-day moving average (MA) of 995.65, below the 50-day MA of 986.88, and below the 200-day MA of 1026.90, indicating a bearish trend. The MACD of -3.52 indicates Positive momentum. The RSI at 42.30 is Neutral, neither overbought nor oversold. The STOCH value of 45.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7090.
LIGUA, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥9.36T | 41.21 | 25.14% | 1.01% | 9.44% | 28.08% | |
78 Outperform | ¥165.95B | 16.09 | 27.95% | 1.97% | 14.57% | 15.03% | |
78 Outperform | ¥53.50B | 10.70 | ― | 3.22% | 11.84% | -5.68% | |
54 Neutral | ¥118.68B | 21.53 | 7.81% | 1.78% | 3.39% | 7.21% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥15.28B | 16.16 | ― | 2.65% | 2.14% | 3.96% | |
40 Underperform | ¥1.44B | -2.25 | ― | ― | -15.77% | 21.26% |
* Healthcare Sector Average
JP:7090
LIGUA, Inc.
891.00
-169.00
-15.94%
JP:7741
HOYA
28,005.00
10,386.78
58.95%
JP:3046
JINS HOLDINGS
7,110.00
-1,566.92
-18.06%
JP:7780
Menicon Co
1,560.00
450.71
40.63%
JP:5889
Japan Eyewear Holdings Co.,Ltd.
2,192.00
-150.67
-6.43%
JP:7743
Seed Co., Ltd.
505.00
63.85
14.47%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.